3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
3
Completed
2
Recruiting
1
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Conditions
Carcinoma, Non-Small-Cell Lung
2709
Lung Neoplasms
2267
Small Cell Lung Carcinoma
452
Breast Neoplasms
394
Neoplasms
348
Colorectal Neoplasms
245
Ovarian Neoplasms
208
Pancreatic Neoplasms
196
Melanoma
196
Prostatic Neoplasms
187
Adenocarcinoma of Lung
184
Neoplasm Metastasis
177
Head and Neck Neoplasms
175
Mesothelioma, Malignant
152
Esophageal Neoplasms
144
Carcinoma, Renal Cell
142
Stomach Neoplasms
141
Colonic Neoplasms
138
Urinary Bladder Neoplasms
124
Mesothelioma
121
Squamous Cell Carcinoma of Head and Neck
115
Uterine Cervical Neoplasms
97
Sarcoma
86
Brain Neoplasms
86
Kidney Neoplasms
82
Carcinoma, Hepatocellular
71
Liver Neoplasms
68
Adenocarcinoma, Bronchiolo-Alveolar
68
Rectal Neoplasms
64
Pleural Effusion, Malignant
64
Interventions
iniparib
1
Gemcitabine
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Squamous Cell Lung Cancer
×
Thoracic
×
Clear all
NCT04261725
2023-01-10
EPIMURE
Centre Hospitalier Universitaire de la Réunion
Completed
60 enrolled
NCT01082549
2016-03-17
ECLIPSE
Sanofi
Phase 3
Completed
780 enrolled